INS and Hepatic steatosis: Increase hepatic mitochondrial energy expenditure; reduce hypertriglyceridemia and hepatic steatosis; reduce hepatic DAGs-PKCε activity and hepatic acetyl-CoA content to reverse hepatic insulin resistance